Cargando…

Intravesical Resiniferatoxin for the Treatment of Storage Lower Urinary Tract Symptoms in Patients with Either Interstitial Cystitis or Detrusor Overactivity: A Meta-Analysis

BACKGROUND: While Resiniferatoxin (RTX) has been widely used for patients with storage lower urinary tract symptoms (LUTS), its clinical efficiency hasn't yet been well evaluated. A meta-analysis was performed to evaluate the exact roles of intravesical RTX for the treatment of storage LUTS in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Changcheng, Yang, Bin, Gu, Wenyu, Peng, Bo, Xia, Shengqiang, Yang, Fengqiang, Wen, Deyi, Geng, Jiang, Zhang, Yuanyuan, Zheng, Junhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869704/ https://www.ncbi.nlm.nih.gov/pubmed/24376550 http://dx.doi.org/10.1371/journal.pone.0082591

Ejemplares similares

Intravesical Liposome and Antisense Treatment for Detrusor Overactivity and Interstitial Cystitis/Painful Bladder Syndrome
por: Tyagi, Pradeep, et al.
Publicado: (2014)

Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
por: Ham, Byeong Kuk, et al.
Publicado: (2012)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Review of intravesical therapies for bladder pain syndrome/interstitial cystitis
por: Cvach, Kristina, et al.
Publicado: (2015)

Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome
por: Downey, A, et al.
Publicado: (2015)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
por: Jiang, Yuan-Hong, et al.
Publicado: (2023)

Safety and efficacy of intravesical instillation of resiniferatoxin in healthy cats: A preliminary study
por: Barletta, Michele, et al.
Publicado: (2023)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
por: Jin, Long-Hu, et al.
Publicado: (2011)

Development and Changes with Age of Detrusor Overactivity in Spontaneous Hypertensive Rats as Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
por: Jin, Long-Hu, et al.
Publicado: (2011)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Interstitial Cystitis Can Be Improved With Intravesical Instillation of Platelet-Rich Plasma
por: Hardy, Timothy J
Publicado: (2022)

Efficacy of intravesical cocktail therapy with or without dimethyl sulphoxide in interstitial cystitis
por: Sogutdelen, Emrullah, et al.
Publicado: (2022)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

AB121. Role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis
por: Yang, Jin-Yi, et al.
Publicado: (2016)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
por: Grundy, Luke, et al.
Publicado: (2018)

Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary–Sant symptom index
por: Pires, Maria Verônica, et al.
Publicado: (2022)

Recurrence after postoperative intravesical instillation therapy in Hunner type interstitial cystitis
por: Ko, Kwang Jin, et al.
Publicado: (2023)

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis
por: Rahnama’i, Mohammad-Sajjad, et al.
Publicado: (2023)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

Time-Related Changes in Detrusor Overactivity in Awake Rats with Spinal Cord Injury Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
por: Jin, Long-Hu, et al.
Publicado: (2011)

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
por: Banakhar, Mai, et al.
Publicado: (2021)

Cajal–like interstitial cells as a novel target in detrusor overactivity treatment: true or myth?
por: Juszczak, Kajetan, et al.
Publicado: (2013)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Alterations of the Myovesical Plexus of the Human Overactive Detrusor
por: Kuijpers, Kamiel A. J., et al.
Publicado: (2014)

Role of detrusor PDGFRα(+) cells in mouse model of cyclophosphamide-induced detrusor overactivity
por: Lee, Haeyeong, et al.
Publicado: (2022)

Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model
por: Sahiner, Ilker Fatih, et al.
Publicado: (2018)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity
por: Hui, C, et al.
Publicado: (2016)

Autonomous Nervous System Activity in Women with Detrusor Overactivity
por: Im, Hyun Wook, et al.
Publicado: (2010)

Urinary nerve growth factor in patients with detrusor overactivity
por: Korzeniecka-Kozerska, A., et al.
Publicado: (2014)

OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children
por: Austin, Paul F., et al.
Publicado: (2020)

In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective?
por: Tomoe, Hikaru
Publicado: (2015)

Changes in Cystoscopic Findings after Intravesical Hyaluronic Acid Instillation Therapy in Patients with Interstitial Cystitis
por: Lin, Chia-Ju, et al.
Publicado: (2022)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
por: Bellucci, Carlos H.S., et al.
Publicado: (2017)

Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome
por: Silva-Ramos, Miguel, et al.
Publicado: (2013)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6guh66v5nukjsoceor16a1vgop